Table 3.
Cancer type | April 2020–March 2021 | April 2019–March 2020 | Difference (%) | p value |
---|---|---|---|---|
Skin | 30.9 (136.6) | 35.4 (175.4) | − 12.8 | 0.025 |
Male genital organs including prostate | 13.0 (57.8) | 13.9 (64.7) | − 6.3 | 0.228 |
Breast | 10.2 (16.3) | 10.8 (20.2) | − 5.2 | 0.674 |
Urinary tract | 6.7 (60.3) | 7.0 (62.7) | − 4.9 | 0.413 |
Digestive organs | 5.5 (8.1) | 6.0 (10.8) | − 8.5 | 0.058 |
Lymphoid, hematopoietic and related tissue | 5.4 (14.1) | 5.8 (16.9) | − 7.3 | 0.220 |
Female genital organs | 3.1 (9.8) | 3.3 (11.9) | − 4.7 | 0.153 |
Respiratory and intrathoracic organs | 2.3 (3.3) | 2.5 (3.7) | − 7.4 | 0.329 |
Thyroid and other endocrine glands | 0.7 (1.9) | 0.8 (1.9) | − 5.0 | 0.187 |
Lip, oral cavity and pharynx | 0.6 (0.9) | 0.6 (1.0) | − 6.8 | 0.413 |
Head/brain | 0.4 (1.0) | 0.5 (1.0) | − 7.4 | 0.171 |
Data are mean (standard deviation) unless otherwise indicated
p values were obtained using Wilcoxon tests